Schedule 13G ownership disclosure

ADC THERAPEUTICS SA

Security class unavailable · CUSIP: H0036K147

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,758,794
Percent of class
8.8100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-023903
Form type
SC 13G
Filer
ADC Therapeutics SA
CIK
CIK 1771910
Filed
Feb 16, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub